You are viewing the site in preview mode

Skip to main content

Volume 6 Supplement 2

Proceedings of the First Biennial Conference on Science of Global Prostate Cancer Disparities in Black Men

Proceedings

Edited by Folakemi T Odedina, Vickie L Shavers, Richard Segal and Shannon Pressey

The Science of Global Prostate Cancer Disparities in Black Men. Go to conference site.

Jacksonville, FL, USA27-29 August 2010

  1. The most common male malignancy in the United States is prostate cancer; however its rate of occurrence varies significantly among ethnic groups. In a previous cDNA microarray study on CaP tumors from African ...

    Authors: R Renee Reams, Krishna Rani Kalari, Honghe Wang, Folakemi T Odedina, Karam FA Soliman and Clayton Yates

    Citation: Infectious Agents and Cancer 2011 6(Suppl 2):S1

    Content type: Proceedings

    Published on:

  2. Prostate cancer is the sixth leading cause of death from cancer among men worldwide. We have previously reported that prostate cancer survival rates for Caribbean-born males in the US was similar to survival r...

    Authors: Camille Ragin, Batsirai Mutetwa, Alison Attong-Rogers, Veronica Roach and Emanuela Taioli

    Citation: Infectious Agents and Cancer 2011 6(Suppl 2):S2

    Content type: Proceedings

    Published on:

  3. The advanced disease clinical presentations, higher morbidity and mortality rates and lack of available treatment options in prostate cancer care, attest to disparities in the delivery and outcomes of urologic...

    Authors: Robin Roberts

    Citation: Infectious Agents and Cancer 2011 6(Suppl 2):S4

    Content type: Proceedings

    Published on:

  4. African-American black men race is one of non-modifiable risk factors confirmed for prostate cancer. Many studies have been done in USA among African- American population to evaluate prostate cancer disparitie...

    Authors: Fasnéwindé A Kabore, Barnabé Zango, Adama Sanou, Clotaire Yameogo and Brahima Kirakoya

    Citation: Infectious Agents and Cancer 2011 6(Suppl 2):S6

    Content type: Proceedings

    Published on:

  5. Androgen deprivation therapy (ADT) has been reported to reduce the bone mineral density (BMD) in men with prostate cancer (CaP). However, Afro-Caribbeans are under-represented in most studies. The aim was to d...

    Authors: Belinda F Morrison, Ingrid E Burrowes, William D Aiken, Richard G Mayhew, Horace M Fletcher and Marvin E Reid

    Citation: Infectious Agents and Cancer 2011 6(Suppl 2):S7

    Content type: Proceedings

    Published on:

  6. Prostate cancer (CaP) disparities in the black man calls for concerted research efforts. This review explores the trend and focus of CaP research activities in Nigeria, one of the ancestral nations for black m...

    Authors: Titilola O Akinremi, Chidiebere N Ogo and Ayodeji O Olutunde

    Citation: Infectious Agents and Cancer 2011 6(Suppl 2):S8

    Content type: Proceedings

    Published on:

  7. Since behavioral factors are significant determinants of population health, addressing prostate cancer (CaP)-related health beliefs and cultural beliefs are key weapons to fight this deadly disease. This study...

    Authors: Folakemi T Odedina, Getachew Dagne, Shannon Pressey, Oladapo Odedina, Frank Emanuel, John Scrivens, R Renee Reams, Angela Adams and Margareth LaRose-Pierre

    Citation: Infectious Agents and Cancer 2011 6(Suppl 2):S10

    Content type: Proceedings

    Published on:

Chairpersons:


Folakemi T. Odedina, PhD
Professor, Pharmaceutical Outcomes and Policy, College of Pharmacy
Director, Community Outreach & Minority Affairs, Prostate Disease Center
University of Florida
Gainesville, Florida, USA


Johannes W. Vieweg, MD, FACS
Professor of Urology
Chairman, Department of Urology
University of Florida
Gainesville, Florida, USA


Conference Coordinator
Shannon Pressey, MS
Research Programs Coordinator
Pharmaceutical Outcomes & Policy,
College of Pharmacy
University of Florida
Gainesville, FL, USA


Scientific Program Committee Chairpersons


Rick Kittles, PhD
Associate Professor
Section of Hematology/ Oncology
Department of Medicine
University of Illinois at Chicago
Chicago, IL, USA


Renee Reams, PhD
Professor
Division of Basic Pharmaceutical Sciences
College Of Pharmacy and
Pharmaceutical Sciences
Florida A& M University
Tallahassee, FL, USA


Carole Kimberlin, PhD
Professor and Graduate Coordinator
Department of Pharmaceutical
Outcomes & Policy
University of Florida
Gainesville, FL USA


Scientific Review Committee Chairpersons


Rich Segal, PhD
Professor and Chair
Department of Pharmaceutical
Outcomes and Policy
University of Florida
Gainesville, FL USA


Robin Roberts, MB BS, FRCSC, MBA
Urologist
Director, University of the West Indies,
School of Clinical Medicine and Research,
The Bahamas
Nassau, Bahamas


Frank Chinegwundoh, MBBS
Consultant Urological Surgeon
St Bartholomew’s Hospital,
Newham University Hospital,
London UK
Honorary Clinical Senior Lecturer, University of London


J. Olufemi Ogunbiyi, MBBS, FWACP, IFCAP
Professor
Department of Pathology
UCH/College of Medicine,
University of Ibadan,
Nigeria


Patient/Physician Symposium Committee Chairpersons


Virgil H. Simons, MBA
Founder & President
The Prostate Net
Hackensack, NJ USA


John Andrews
The Prostate Net


Community Engagement & Advocacy Committee Chairpersons


Angela Adams, PharmD
Executive Director,
The Central Florida Pharmacy Council
Orlando, FL, USA


Charles Griggs, MS
100 Black Men Jacksonville Inc.


Titilola Akinremi, MBChB, FMCPath, MPH, FUICC
Chief Consultant Anatomic Pathologist
Head, Department of Pathology
Chairman, Educational Advisory Committee
Chairman, Health Research Ethics Committee
Federal Medical Center, Abeokuta,
Ogun State, Nigeria


Conference Logistics, PR & Marketing Committee


John Andrews
The Prostate Net


Levi H. McIntosh, Jr. ED.D.
Vice President of Operations
100 Black men of Jacksonville, Inc
Program Coordinator APEL Health Services
Jacksonville, FL, USA


Helen Goh
Director, Outreach and Communications
Department of Urology, College of Medicine
University of Florida
Gainesville, FL, USA


Shannon Pressey, MS
Research Programs Coordinator
Pharmaceutical Outcomes & Policy,
College of Pharmacy
University of Florida
Gainesville, FL, USA


Sponsorship


Funding for this conference was made possible, in part, by an award provided by the Division of
Cancer Control and Population Sciences and the Division of Cancer Prevention of the National
Cancer Institute (Award Number R13CA144439) and an educational grant (Grant Number
57377) from AstraZeneca.


The conference was organized by the University of Florida Department of Urology, University of
Florida Department of Pharmaceutical Outcomes and Policy, The Prostate Net, and the 100
Black Men of Jacksonville.


Additional sponsors were Mayo Clinic Jacksonville, FL; Abeokuta Federal Medical Centre, Ogun
State, Nigeria; Olabisi Onabanjo University Teaching Hospital, Ogun State, Nigeria; University
of Florida Shands Cancer Center, Gainesville, FL; H. Lee Moffitt Cancer Center, Tampa, FL;
First Coast Audio Visual, Jacksonville, FL; and University of Florida Shands Jacksonville, FL.

Annual Journal Metrics